Stinghen, Andréa E M <br/><br/>
Immune mechanisms involved in cardiovascular complications of chronic kidney disease.  [electronic resource] 

 -  Blood purification  2010 
 - 114-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1421-9735 
<br/><br/><label>Standard No.: </label>10.1159/000245636  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antihypertensive Agents--therapeutic use<br/>Antioxidants--therapeutic use<br/>Atherosclerosis--etiology<br/>Cardiomyopathies--etiology<br/>Cardiovascular Diseases--etiology<br/>Chronic Disease<br/>Clinical Trials as Topic<br/>Endothelium, Vascular--physiopathology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Inflammation--drug therapy<br/>Interleukin-6--metabolism<br/>Kidney Diseases--complications<br/>Membranes, Artificial<br/>Mice<br/>Periodontitis--complications<br/>Renal Dialysis--adverse effects<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Vasculitis--etiology